Charité - Universitätsmedizin Berlin

Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review. (2017) Heppt MV, Steeb T, Schlager JG, Rosumeck S, Dressler C, Ruzicka T, Nast A, Berking C Journal article, Review article Human campylobacteriosis (2017) Backert S, Tegtmeyer N, Croinin TO, Böhm M, Heimesaat MM Book chapter / Article in edited volumes Brain Slices From Human Resected Tissues (2017) Heinemann U, Gabriel S, Angamo EA, Salar S, Lehmann TN, Dengler N Book chapter / Article in edited volumes Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly (2017) Van Der Lely AJ, Gomez R, Pleil A, Badia X, Brue T, Buchfelder M, Burman P, et al. Journal article The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update (2017) Catassi C, Alaedini A, Bojarski C, Bonaz B, Bouma G, Carroccio A, Castillejo G, et al. Journal article Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform (2017) Messroghli DR, Pickardt T, Fischer M, Opgen-Rhein B, Papakostas K, Bocker D, Jakob A, et al. Journal article Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) (2017) Kuemmel S, Paepke S, Huober J, Schem C, Untch M, Blohmer JU, Eiermann W, et al. Journal article Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto) (2017) Untch M, Schneeweiss A, Salat C, Rezai M, Zahm DM, Klare P, Blohmer JU, et al. Conference contribution OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS OF THE NON-INTERVENTIONAL STUDY C-PATROL (2017) Marme F, Sehouli J, Welslau M, Schinkoethe T, El-Balat A, Fasching P, Glowik R, Hilpert F Conference contribution Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE) (2017) Loibl S, De La Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, et al. Journal article